• Donate
  • Login
Tuesday, December 9, 2025
  • Login
  • Register
Canary
Cart / £0.00

No products in the basket.

MEDIA THAT DISRUPTS
  • UK
  • Global
  • Opinion
  • Skwawkbox
  • Manage Subscription
  • Support
  • Features
    • Health
    • Environment
    • Science
    • Feature
    • Sport & Gaming
    • Lifestyle
    • Tech
    • Business
    • Money
    • Travel
    • Property
    • Food
    • Media
No Result
View All Result
MANAGE SUBSCRIPTION
SUPPORT
  • UK
  • Global
  • Opinion
  • Skwawkbox
  • Manage Subscription
  • Support
  • Features
    • Health
    • Environment
    • Science
    • Feature
    • Sport & Gaming
    • Lifestyle
    • Tech
    • Business
    • Money
    • Travel
    • Property
    • Food
    • Media
No Result
View All Result
Canary
No Result
View All Result

‘Potent’ experimental drug given to Trump already being used in UK

The Canary by The Canary
21 August 2025
in Global, Health, Other News & Features, Science, UK
Reading Time: 2 mins read
169 5
A A
0
Home Global
Share on FacebookShare on TwitterShare on BlueskyShare via WhatsAppShare via TelegramShare on Threads

A “very potent” experimental coronavirus drug being given to Donald Trump is already being used in a handful of UK hospitals, according to an Oxford University professor.

The US president was given the artificial antibody treatment at the White House on Friday 2 October after being diagnosed with coronavirus (Covid-19). This was before he was taken to Walter Reed National Military Medical Centre.

The drug is already being used in “about three hospitals in the north” as part of Oxford University’s national Recovery trial, said Professor Peter Horby.

“Very promising”

Prof Horby added that the drug is due to be rolled out to “another 30 to 40 hospitals” in the UK from the week beginning 5 October. He specialises in emerging infectious diseases at Oxford University and is co-chief investigator of the Recovery trial.

Speaking on BBC Radio 4’s Today programme on morning of Saturday 3 October, Prof Horby described the drug as “very promising” and “very potent”.

He said:

The class of drugs, these artificial antibodies, have been around for quite a while now, and they’ve been extensively used in inflammatory conditions and cancers, and they’re pretty safe and well understood, and so the technology is something that I think we have confidence in.

This particular drug has probably been given to, I would think now, four or five hundred patients, mild or severe patients in different trials, and so far there’s been no worrying safety signals.

In the laboratory, in cell cultures it has a very strong effect against the virus, and there have been studies in artificial animals where it also shows benefits. So probably of the drugs that are available, it’s one of the most promising.

How it works

Prof Horby said a single dose of the treatment provides “prolonged protection” for “a month to six weeks”. He said this makes it “quite attractive for the older population”.

The antibody cocktail works by binding to a protein on the surface of the virus. This stops the virus from attaching to cells and replicating, while allowing the immune system to attack the virus.

Trump has been given the drug alongside Remdesivir. It’s an antiviral treatment which has been shown to help some coronavirus patients recover faster.

His wife Melania and one of Trump’s closest aides also tested positive for coronavirus on Friday 2 October.

Tags: Coronavirus
Share130Tweet81ShareSendShareShare
Previous Post

Russian journalist sets herself on fire and dies near police HQ

Next Post

‘Anger and revulsion’ as Irish journalist says special education needs funding is ‘not sustainable’

Next Post
Ben Lowry & a classroom

‘Anger and revulsion’ as Irish journalist says special education needs funding is ‘not sustainable’

University opening too soon and ministers breaking rules to blame for Northumbria outbreak, pupils and parents say

University opening too soon and ministers breaking rules to blame for Northumbria outbreak, pupils and parents say

Joe Biden, Donald Trump, and Bernie Sanders

Never mind the presidential debate. Here is the real video we should all be watching.

Boris Johnsons cabinet of horrors

Britain's status as rogue state confirmed, thanks to latest moves by the Johnson Gang to flout international laws

Outside Old Bailey

Journalism on trial: an eyewitness account of Julian Assange’s extradition hearing

Please login to join discussion
Israel
Analysis

Israel executes two unarmed Palestinians after they surrendered

by Charlie Jaay
28 November 2025
Palestine Action
Analysis

Disabled arrestee refuses to be silent, saying “freedom is not to be taken from us without a fight”

by Ed Sykes
28 November 2025
Syria
Analysis

Syria: Fragile peace after Bedouin murders ignite sectarian tensions

by Alex/Rose Cocker
28 November 2025
Barghouti
Skwawkbox

Video: Barghouti honoured with new mural after 24 years as Israel’s political prisoner

by Skwawkbox
28 November 2025
palestine action
Analysis

Shocking new report reveals what really drove the government’s crackdown on Palestine Action

by The Canary
28 November 2025
  • Get our Daily News Email

The Canary
PO Box 71199
LONDON
SE20 9EX

Canary Media Ltd – registered in England. Company registration number 09788095.

For guest posting, contact ben@thecanary.co

For other enquiries, contact: hello@thecanary.co

Sign up for the Canary's free newsletter and get disruptive journalism in your inbox twice a day. Join us here.

© Canary Media Ltd 2024, all rights reserved | Website by Monster | Hosted by Krystal | Privacy Settings

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
  • UK
  • Global
  • Opinion
  • Skwawkbox
  • Manage Subscription
  • Support
  • Features
    • Health
    • Environment
    • Science
    • Feature
    • Sport & Gaming
    • Lifestyle
    • Tech
    • Business
    • Money
    • Travel
    • Property
    • Food
    • Media
  • Login
  • Sign Up
  • Cart